Updates are available Correction dated 2020-11-23
Click to view Correction: https://doi.org/10.1186/s13063-020-04900-3
-
Authors
,
Gonzalez-Bermejo, J.
Hajage, D.
Durand-Zaleski, I.
Arnal, J. M.
Cuvelier, A.
Grassion, L.
Jaffre, S.
Lamia, B.
Pontier, S.
Prigent, A.
Rabec, C.
Raherison-Semjen, C.
Saint Raymond, C.
Soler, J.
Trzepizur, W.
Winck, J. C.
Aguiar, M.
Chaves, H.
Conde, B.
Guimarães, M. J.
Lopes, P.
Mineiro, A.
Moreira, S.
Pamplona, P.
Rodrigues, C. M.
Sousa, S.
Antón, A.
Córdoba-Izquierdo, A.
Embid, C.
Esteban González, C.
Ezzine, F.
Garcia, P.
González, M.
Guerassimova, I.
López, D.
Lujan, M.
Martí Beltran, S.
Martinez, J. M.
Masa, F.
Pascual, N.
Peñacoba, N.
Resano, P.
Rey, L.
Rodríguez Jerez, F.
Roncero, A.
Sancho Chinesta, Je.
Sayas Catalán, Ja
- License Information
-
More Information
Article History
Received: 7 April 2020
Accepted: 12 August 2020
First Online: 22 October 2020
Change Date: 23 November 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via the original article.
Ethics approval and consent to participate
: Version 1.0 of the protocol was approved by the Ethics Committee (Ile de France 1, Hôpital Hôtel-Dieu; file number 2019 nov.-MS235) on September 11, 2018; with three minor amendments, the current protocol version 4.0 dated 28/05/2019 was approved on June 11, 2019.The study will not begin in Portugal nor Spain, before required approval has equally been obtained in these countries.In accordance with the Good Clinical Practice (GCP) guidelines and as described in the study procedure, a written informed consent will be obtained from all participants before any participation in the study.
: Not applicable.
: The authors declare that they have no competing interests.
